You just read:

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

News provided by

Mylan N.V. , Biocon Ltd.

Dec 27, 2016, 08:00 ET